Results and Ongoing Studies from the MFM Network
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In the early 1970's, fetal monitoring technology escaped from the laboratory into the clinical environment in a rapid, almost chaotic sequence of events. The assumption upon which fetal monitoring was based was that most mental retardation and cerebral palsy occurs from lack of oxygen during labor, and is therefore preventable. We now that this assumption if false and the benefits of fetal monitoring are seemingly far less than originally hoped. In contrast, the NIH Maternal Fetal Medicine network is a very well designed approach to evaluating treatments before they become the standard of care. In this segment, Dr. Spong overviews some of the prior to currently active studies being conducted by this organization.
Overview
In the early 1970's, fetal monitoring technology escaped from the laboratory into the clinical environment in a rapid, almost chaotic sequence of events. The assumption upon which fetal monitoring was based was that most mental retardation and cerebral palsy occurs from lack of oxygen during labor, and is therefore preventable. We now that this assumption if false and the benefits of fetal monitoring are seemingly far less than originally hoped. In contrast, the NIH Maternal Fetal Medicine network is a very well designed approach to evaluating treatments before they become the standard of care. In this segment, Dr. Spong overviews some of the prior to currently active studies being conducted by this organization.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Diagnosis and Management of Metastatic PDAC
HF Management for Patients with Comorbid Conditions
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Second-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?